1-3 of 3
Simon Joel, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SKIP Is Underexpressed in AML Leading to Sphingosine Kinase Hypofunction

Essam Ghazaly, MD PhD, Paul Smith, PhD, Chathunissa Gnanaranjan, MSc, Bryan D Young, BSc, PhD, Simon Joel, PhD, John G. Gribben, MD DSc, David C Taussig, PhD MRCP, FRCPath
Journal: Blood
Blood (2014) 124 (21): 5324.
https://doi.org/10.1182/blood.V124.21.5324.5324
Published: 2014
Journal Articles

A European Phase II Study (BIOV-111) of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia: Final Results.

Pamela Kearns, MD, PhD, Gerard Michel, MD, Brigitte Nelken, MD, Simon Joel, PhD, Essam Al-Ghazaly, PhD, Auke Beishuizen, MD, PhD, Valentino Conter, MD, Gunter Henze, MD, Andre Baruchel, MD, Vaskar Saha, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 11.
https://doi.org/10.1182/blood.V110.11.11.11
Published: 2007
Journal Articles

BIOV-111 a European Phase II Trial of Clofarabine (Evoltra ® ) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia.

Pamela Kearns, MD,PhD, Gerard Michel, MD, Brigitte Nelken, MD, Simon Joel, PhD, Essam Al-Ghazaly, MD, Auke Beishuizen, MD,PhD, Valentino Conter, MD, Helmut Gadner, MD, Gunter Henze, MD, Hazel Smith, PhD, Andre Baruchel, MD, Vaskar Saha, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1859.
https://doi.org/10.1182/blood.V108.11.1859.1859
Published: 2006